Banned Scientific Breakthrough
Safely Boosts Brain Power to
‘Superhuman Levels’

Grouping of Logos

All over the Internet, people are scrambling to get their hands on ‘IQ’–– a controversial new “smart pill” that the Olympics and even Ivy-League Universities are banning. They claim this intelligence-enhancer gives anyone who uses it an “unfair advantage”––allowing you to work better, be more focused, and activate higher levels of creativity.

an image of a brain

Why Is Everyone Keeping This a Secret?

Alpha Levo IQ has drawn comparisons to Adderall and Ritalin, because all three pills are popular among healthy people who take them to study or work on big projects. But unlike Adderall and Ritalin, Alpha Levo doesn't have the same potential for addiction and abuse, and is healthy enough to take several times a day, every day.

An image

How This Assistant Doubled His Income In
Just a Few Hours...

A 33-year-old executive assistant named Brian, who chose to be identified by only his first name, told Brain Science Daily that he first used the “brain booster” last year after he found a bottle stashed inside a hidden drawer in his bosses desk.

An image of Brian
Brian
Executive Assistant

"I tried just half of one and it worked.” Brian said. “Your level of focus goes through the roof. You have more energy. Your cognitive abilities get better. Things just make more sense."

He decided to “test” his newly-enhanced intelligence by playing the stock market every day after work. Within 3 months, Brian made $32,537. His only complaint is that he achieved all his goals much quicker than he ever imagined, so he’s had to set bigger ones in order to keep life interesting.

“Everything seems easier…like I just unlocked the other 90% of my brain. I can see why my boss had those bottles stashed away. It’s powerful stuff.”

Is This What Billionaires Are Using to Get
Rich?

It’s been widely suspected that high-ranking executives and some of the “privileged elite” have been using Alpha Levo IQ to wipe the floor with their competitors and get filthy rich. A not-so-hidden-secret is that one of the newest entries to the Forbes Billionaire List started his company a few days after he chose to order a bottle and begin taking it.

And that’s why it’s been so controversial. Results have proven that anyone who uses this new intelligence-enhancer gains an overwhelming (and unfair) advantage over everyone around them. It’s no wonder institutions like the Olympics are banning its use from competition, and other organizations are following suit. At this rate, it’s becoming harder and harder to get your hands on a bottle.

An image of a selection of newsletters

Just How Powerful Is It?

All of this evidence supporting the power of Alpha Levo was enough to get me to try my own personal experiment. I encouraged our Chief Editor to buy a one month supply of Alpha Levo, so I could write about it for our magazine. Below is a week-by-week account of what happened:

WEEK 1:

I had to wait weeks to begin because my Editor said that Alpha Levo was backordered. There was a huge demand after it was profiled on the news, so we had to wait for them to restock. Once I was able to get my hands on a bottle I began my experiment.

The first week using it was incredible. My focus was superhuman. I’m a writer, so procrastination is deeply rooted in my DNA. But this week I began and finished more projects than I ever have! Even my editor was impressed. He said he was going to order another shipment just to make sure I hit my deadlines next month too!

(Side note: no negative effects at all. Much different than Adderall.)

WEEK 2:

I’m a big guy, 6’ 200 pounds, and I have a high tolerance, so I was worried that Alpha Levo would stop working for me if I took it every day. Not at all. Is it possible that I’m feeling even better this week than I did last week? I think so. Productivity is still insanely high but I’ve also noticed a positive effect on my mood. I’m just happier. Not a sloppy alcohol kind of happy, just a general, positive motivated mood. Me like.

Brain Activity Meter
brain scan image

WEEK 3:

I’ve noticed that my memory has dramatically improved since taking Alpha Levo. i used to forget little things like where I put my keys or where my car was in the parking lot, but not anymore. Because of this, I’ve began to take half a pill before reading, and I’m noticing that I retain more information when I do that. I can quote passages from books that I read weeks ago, word for word. Wow, am I becoming a superhero?

WEEK 4:

So I just got a promotion at work. I’m not going to say that it was all because of Alpha Levo…I mean, I worked really hard this past month. But the work just seemed so much easier than ever before, and that only happened after I started taking this pill every day. Work isn’t the only thing that’s easy, I speak with more confidence and my uplifted mood has me approaching more women. I’ve gone on more dates too! I think it’s funny that they call this a “smart pill”, it should be called an “everything in your life gets better” pill. I can’t wait for my next shipment.

My results: After reading all the studies and reviews on Alpha Levo IQ, I knew something good was going to happen…but i has no idea my results would be this dramatically positive. Everything in my life got easier, I became more confident, and my mood has been better than it’s ever been. Not only that, but my creativity seemed to increase, and ideas came to me faster and more powerfully.

 

I like to stay unbiased but it’s hard for me to give this anything but a glowing review. You need to try Alpha Levo IQ for yourself. It won’t take long for you to realize why everybody is talking about this smart pill. It just works. You can get an exclusive discounted bottle for yourself by clicking this link.

an image of bottles of alpha-levo iq

WARNING: Alpha Levo IQ was specifically formulated to induce rapid cognitive development in anyone that takes it. Increased intelligence is a responsibility not to be taken lightly. Please prepare yourself for what could be a profound change in your life circumstances

an image of facebook testimonials about prolazyme
Study Name Link
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. http://www.ncbi.nlm.nih.gov/pubmed/23326356
Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. http://www.ncbi.nlm.nih.gov/pubmed/16808927?dopt=Abstract
Ginkgo biloba extract regulates differentially the cell death induced by hydrogen peroxide and simvastatin. http://www.ncbi.nlm.nih.gov/pubmed/16185767
Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. http://www.ncbi.nlm.nih.gov/pubmed/8364946
The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. http://www.ncbi.nlm.nih.gov/pubmed/10441781?dopt=Abstract
Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. http://www.ncbi.nlm.nih.gov/pubmed/12404561?dopt=Abstract
Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. http://www.ncbi.nlm.nih.gov/pubmed/11466162?dopt=Abstract
Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers. http://www.ncbi.nlm.nih.gov/pubmed/21802920?dopt=Abstract
The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. http://www.ncbi.nlm.nih.gov/pubmed/10441781?dopt=Abstract
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. http://www.ncbi.nlm.nih.gov/pubmed/11140327?dopt=Abstract
Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. http://www.ncbi.nlm.nih.gov/pubmed/20737519?dopt=Abstract
Effect of a standardized ginseng extract on general well-being, reaction time, lung function and gonadal hormones http://www.ncbi.nlm.nih.gov/pubmed/7231139?dopt=Abstract
Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. http://www.ncbi.nlm.nih.gov/pubmed/15982990?dopt=Abstract
Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks. http://www.ncbi.nlm.nih.gov/pubmed/16401645?dopt=Abstract
Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. http://www.ncbi.nlm.nih.gov/pubmed/15582012?dopt=Abstract
Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. http://www.ncbi.nlm.nih.gov/pubmed/12404705?dopt=Abstract
The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. http://www.ncbi.nlm.nih.gov/pubmed/11140327?dopt=Abstract
Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. http://www.ncbi.nlm.nih.gov/pubmed/10678121
The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. http://www.ncbi.nlm.nih.gov/pubmed/23495677
Effects of phosphatidylserine in age-associated memory impairment. http://www.ncbi.nlm.nih.gov/pubmed/2027477
Effect of phosphatidylcholine on explicit memory. http://www.ncbi.nlm.nih.gov/pubmed/9377589?dopt=Abstract
Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. http://www.ncbi.nlm.nih.gov/pubmed/12404561
Effects of Korean red ginseng extract on behavior in children with symptoms of inattention and hyperactivity/impulsivity: a double-blind randomized placebo-controlled trial. http://www.ncbi.nlm.nih.gov/pubmed/25369174
A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficithyperactivity disorder in fragile X syndrome boys. http://www.ncbi.nlm.nih.gov/pubmed/18286595
L-acetylcarnitine treatment of mental decline in the elderly. http://www.ncbi.nlm.nih.gov/pubmed/7813389?dopt=Abstract
Acetyl-L-carnitine in the treatment of mildly demented elderly patients. http://www.ncbi.nlm.nih.gov/pubmed/2201659?dopt=Abstract
Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism. http://www.ncbi.nlm.nih.gov/pubmed/2201652?dopt=Abstract
Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders. http://www.ncbi.nlm.nih.gov/pubmed/2099360?dopt=Abstract
Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. http://www.ncbi.nlm.nih.gov/pubmed/14687872?dopt=Abstract
A controlled trial of homocysteine lowering and cognitive performance. http://www.ncbi.nlm.nih.gov/pubmed/16807413?dopt=Abstract
Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials http://www.ncbi.nlm.nih.gov/pubmed/17210874?dopt=Abstract
Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. http://www.ncbi.nlm.nih.gov/pubmed/22232016?dopt=Abstract
A controlled trial of homocysteine lowering and cognitive performance. http://www.ncbi.nlm.nih.gov/pubmed/16807413?dopt=Abstract
Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. http://www.ncbi.nlm.nih.gov/pubmed/22232016?dopt=Abstract
Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. http://www.ncbi.nlm.nih.gov/pubmed/8323999?dopt=Abstract
Effects of phosphatidylserine in age-associated memory impairment. http://www.ncbi.nlm.nih.gov/pubmed/2027477?dopt=Abstract
Double-blind randomized controlled study of phosphatidylserine in senile demented patients. http://www.ncbi.nlm.nih.gov/pubmed/3518329?dopt=Abstract
An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. http://www.ncbi.nlm.nih.gov/pubmed/11201936?dopt=Abstract
Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. http://www.ncbi.nlm.nih.gov/pubmed/8038871?dopt=Abstract
Effects of phosphatidylserine in Alzheimer's disease. http://www.ncbi.nlm.nih.gov/pubmed/1609044?dopt=Abstract
Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. http://www.ncbi.nlm.nih.gov/pubmed/1633433?dopt=Abstract
A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. http://www.ncbi.nlm.nih.gov/pubmed/3553281?dopt=Abstract
Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases http://www.ncbi.nlm.nih.gov/pubmed/3949275?dopt=Abstract
Vinpocetine effects on cognitive impairments produced by flunitrazepam. http://www.ncbi.nlm.nih.gov/pubmed/3693872?dopt=Abstract
Psychopharmacological effects of vinpocetine in normal healthy volunteers. http://www.ncbi.nlm.nih.gov/pubmed/3899677?dopt=Abstract
Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. http://www.ncbi.nlm.nih.gov/pubmed/12404561?dopt=Abstract
Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease http://www.ncbi.nlm.nih.gov/pubmed/8701750?dopt=Abstract
Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students http://www.ncbi.nlm.nih.gov/pubmed/10678121?dopt=Abstract
Effect of huperzine A on memory function of patients with mild cognitive impairment. - Wang, W; Zhongguo Linchuang Kangfu 2005;9(8):23. N/A